NeuroBo Pharmaceuticals Inc. (NRBO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NeuroBo Pharmaceuticals I...

    NASDAQ: NRBO · Real-Time Price · USD
    2.36
    null (null%)
    At close: Nov 27, 2024, 10:00 PM

    NeuroBo Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -27.59M -12.47M -13.97M -15.28M
    Depreciation & Amortization
    		 20K 6K 28K 48K
    Stock-Based Compensation
    		 538K 222K 854K 662.00
    Other Working Capital
    		 n/a 4.28M -966K 578K
    Other Non-Cash Items
    		 2.32M -2.95M 2.55M 24K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 n/a 4.4M -1.17M -584K
    Operating Cash Flow
    		 -24.71M -10.8M -11.71M -15.13M
    Capital Expenditures
    		 -8K -50K n/a -3K
    Cash Acquisitions
    		 n/a n/a 8K -583
    Purchase of Investments
    		 20M n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 -20M n/a 8.00 -582.42K
    Investing Cash Flow
    		 -8K -50K 8K -586K
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 18.3M -80K -35.82M -1.97M
    Financial Cash Flow
    		 18.3M -80K 28.68M 22.03M
    Net Cash Flow
    		 -6.42M -10.93M 16.98M 6.3M
    Free Cash Flow
    		 -24.72M -10.85M -11.71M -15.14M

    Add to Watchlist